Source: Journal of Mass Spectrometry. Unidade: ICB
Assunto: FARMACOLOGIA
ABNT
RIBEIRO, Wellington et al. Determination of RSD921 in human plasma by high-performance liquid chromatography-tandem mass spectometry tri-deuterated RDS921 as internal standard: Application to a phase I clinical trial. Journal of Mass Spectrometry, v. 36, p. 1133-1139, 2001Tradução . . Disponível em: https://doi.org/10.1002/jms.218. Acesso em: 10 nov. 2024.APA
Ribeiro, W., Ifa, D. R., Corso, G., Salmon, J., Eberlin, M. N., Moraes, L. A., & De Nucci, G. (2001). Determination of RSD921 in human plasma by high-performance liquid chromatography-tandem mass spectometry tri-deuterated RDS921 as internal standard: Application to a phase I clinical trial. Journal of Mass Spectrometry, 36, 1133-1139. doi:10.1002/jms.218NLM
Ribeiro W, Ifa DR, Corso G, Salmon J, Eberlin MN, Moraes LA, De Nucci G. Determination of RSD921 in human plasma by high-performance liquid chromatography-tandem mass spectometry tri-deuterated RDS921 as internal standard: Application to a phase I clinical trial [Internet]. Journal of Mass Spectrometry. 2001 ; 36 1133-1139.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1002/jms.218Vancouver
Ribeiro W, Ifa DR, Corso G, Salmon J, Eberlin MN, Moraes LA, De Nucci G. Determination of RSD921 in human plasma by high-performance liquid chromatography-tandem mass spectometry tri-deuterated RDS921 as internal standard: Application to a phase I clinical trial [Internet]. Journal of Mass Spectrometry. 2001 ; 36 1133-1139.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1002/jms.218